Financial Results for the Financial Year ended 31/03/2026

Revenue Growth 20pctPat NegativeEbitda Margin CompressionNegative Operating CashflowResults View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.1%Reaction day

₹81.50

prior close

₹80.81

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-7.2% vs market

Pharmaceuticals peers, median of 160sector+0.2%-6.3% vs sector

On the reaction day the stock moved 7.2 pts less than Nifty Microcap 250 and 6.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.5

10m

-3.5

15m

-4.3

30m

-4.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.1+1.1-7.2+0.2-6.3

Next day

-6.2+1.2-7.4+0.2-6.4

-6.3+2.8-9.1+1.5-7.8

-6.1+3.5-9.7+1.4-7.6

-6.1+3.5-9.6+1.6-7.7

-6.1+2.8-9.0+1.0-7.2

-7.5+2.8-10.3+0.4-7.9

15d

-2.5+4.2-6.7+0.7-3.2

-3.2+10.1-13.3+3.1-6.3

-1.4+10.0-11.4+7.2-8.6

-6.3+14.6-20.8+8.2-14.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma reported total revenue of Rs 77,601.30 Lakhs for FY26, up 15.6% from Rs 67,097.02 Lakhs in FY25, driven by growth in revenue from operations to Rs 77,165.74 Lakhs. However, profit after tax declined 13.3% to Rs 4,104.61 Lakhs from Rs 4,735.19 Lakhs, impacted by rising cost of materials (Rs 51,044.32 Lakhs vs Rs 46,327.71 Lakhs) and increased other expenses. EBITDA margin compressed from 10.64% to 8.56%. The company issued bonus shares in 1:1 ratio during the year. Statutory auditors issued an unmodified opinion. Operating cash flow turned negative at Rs -301.16 Lakhs (vs +Rs 3,712.47 Lakhs in FY25) due to significant inventory buildup of Rs 7,327.41 Lakhs.

Likely market impact

Revenue growth was offset by cost pressures and margin compression; PAT decline and negative operating cash flow are concerning signals for shareholders despite the unqualified audit opinion.